Power Law company profile

Ovid Therapeutics

Biotech & Life Sciences · New York City, United States · Founded 2014 · IPO 2017 Thoroughbred

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$409M

Market cap · Apr/2026

Revenue

$7.3M

Latest reported FY

Investors

11 investors on Ovid Therapeutics's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series B+ 11 investors entered at this stage

Global footprint

AI talent share

2.5% of workforce is AI talent
(1 of 40 staff)

Core AI12.5%

Other AI00%

Non-AI workforce3997.5%

Web traffic by country

7.2K monthly visits
across markets

🇺🇸 United States80.6%

🇮🇳 India18.1%

🇬🇧 United Kingdom1.4%

Top 3 markets shown

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo